ArticleProceedings of the National Academy of Sciences of the United States of America2013

Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32.

Sarah A Stanley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.